Genome Compiler is a technology company.
Genome Compiler has raised $6.0M across 1 funding round.
Key people at Genome Compiler.
Genome Compiler was founded by Omri Amirav Drory (Founder & CEO).
Genome Compiler has raised $6.0M in total across 1 funding round.
Key people at Genome Compiler.
Genome Compiler was founded by Omri Amirav Drory (Founder & CEO).
Genome Compiler has raised $6.0M in total across 1 funding round.
Genome Compiler's investors include ACME Capital, Aleph VC, BoxGroup, Entrée Capital Ventures, General Catalyst, Graph Ventures, NFX, Quiet Capital, Raine Ventures, Rainfall Ventures, Semble Ventures, Slow Ventures.
Genome Compiler is a synthetic biology software company that develops an all-in-one platform for genetic engineers and synthetic biologists to design, edit, and compile custom DNA sequences.[1][2][3] The platform serves researchers, biochemists, and biochemical engineers by solving the challenge of manually assembling genetic code, enabling users to build novel organisms—like bacteria for environmental cleanup or energy production—through simple drag-and-drop interfaces on laptops.[2] It pulls from vast libraries of sequenced genomes (viruses, bacteria), allows gene additions, mutations, and orders physical DNA synthesis from labs like GenScript, democratizing synthetic biology as genome reading costs plummet.[2]
Founded in 2011 as an American-Israeli startup, Genome Compiler operates in the software and internet services industry, focusing on computer-aided design (CAD) and collaboration tools tailored for synbio workflows.[3][4][5] Early traction came from making complex genetic programming accessible, akin to coding software, with built-in biosecurity to prevent misuse.[2]
Genome Compiler was founded in 2011 by Omri Amirav-Drory, a Fulbright Scholar with a Ph.D. from Tel Aviv University in biochemical engineering and computer science, alongside co-founder Reese Jones.[2][4] Amirav-Drory bridged these fields after recognizing that "computers understand code and living things understand the language of DNA," inspired by falling genome sequencing costs that had sequenced thousands of organisms but lacked easy editing tools.[2]
The idea emerged from Amirav-Drory's vision to merge software engineering with biology, allowing scientists to "write their own genetic code" via an intuitive app—demonstrated publicly by editing bacterial genes at a Starbucks on a MacBook.[2] As an American-Israeli startup, it quickly gained attention for putting synthetic biology "in the hands of the masses," with early versions enabling custom DNA assembly from existing life forms.[5]
Genome Compiler rides the synthetic biology wave, fueled by plummeting genome sequencing costs (bacterial DNA now ~$1,000s vs. human genome's billions) and rising demand for engineered microbes in sustainability, biofuels, and biotech.[2] Timing is ideal amid synbio's explosion—post-2010s sequencing booms—positioning it as a key enabler for "programming life" like software, accelerating R&D in climate tech and health.[1][2]
Market forces like open genome databases (e.g., NIH) and DNA synthesis services amplify its impact, lowering barriers for non-experts and fostering a collaborative ecosystem.[2][3] It influences the landscape by democratizing tools once limited to elite labs, spurring innovation in bio-manufacturing and potentially transforming industries like clean energy.[5]
Genome Compiler is poised to scale as synbio matures, with AI integrations likely enhancing design automation and predictive modeling for complex organisms. Trends like cheaper synthesis, regulatory easing for safe microbes, and climate-driven bio-solutions will propel growth, evolving it from niche CAD to a standard platform in biotech stacks. Its influence may expand via partnerships with synthesis giants, amplifying custom organism creation while upholding biosecurity—ultimately making "Genome Compiler" synonymous with accessible life programming, as pioneered by its founders' bold fusion of code and DNA.[2]
Genome Compiler has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in June 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2015 | $6.0M Seed | ACME Capital, Aleph VC, BoxGroup, Entrée Capital Ventures, General Catalyst, Graph Ventures, NFX, Quiet Capital, Raine Ventures, Rainfall Ventures, Semble Ventures, Slow Ventures, Tau Ventures, Webtalk Ltd, Jared Leto, Josh Elman, Mike Vernal, Ron Gura, Shervin Pishevar |
